139
Views
0
CrossRef citations to date
0
Altmetric
Case Report

Electrochemotherapy: a Good Idea in Recurrent Basal Cell Carcinoma Treatment

, , , , , & show all
Pages 27-31 | Published online: 25 Feb 2015

References

  • Lomas A , Leonardi-BeeJ , Bath-HextallF . A systematic review of worldwide incidence of non melanoma skin cancer . Br. J. Dermatol.166 ( 5 ), 1069 – 1080 ( 2012 ).
  • Trakatelli M , MortonC , NagoreEet al. Update of the European guidelines for basal cell carcinoma management . Eur. J. Dermatol. doi:10.1016/j.critrevonc.2014.05.005 ( 2014 ) ( Epub ahead of print ).
  • Lovatt TJ , LearJT , BastrillesJet al. Associations between ultraviolet radiation, basal cell carcinoma site and histology, host characteristics, and rate of development of further tumors . J. Am. Acad. Dermatol.52 , 468 – 473 ( 2005 ).
  • Reinau D , SurberC , JickSS , MeierCR . Epidemiology of basal cell carcinoma in the United Kingdom: incidence, lifestyle factors, and comorbidities . Br. J. Cancer doi:10.1038/bjc.2014.265 ( 2014 ) ( Epub ahead of print ).
  • Richmond-Sinclair NM , PandeyaN , WareRSet al. Incidence of basal cell carcinoma multiplicity and detailed anatomic distribution: longitudinal study of an Australian population . J. Invest. Dermatol.129 ( 2 ), 323 ( 2009 ).
  • Rubin AI , ChenEH , RatnerD . Basal cell carcinoma . N. Engl. J. Med.353 , 2262 – 2269 ( 2005 ).
  • McCusker M , Basset-SeguinN , DummerRet al. Metastatic basal cell carcinoma: prognosis dependent on anatomic site and spread of disease . Eur. J. Cancer50 ( 4 ), 774 – 783 ( 2014 ).
  • Schell AE , RussellMA , ParkSS . Suggested excisional margins for cutaneous malignant lesions based on Mohs micrographic surgery . JAMA Facial Plast. Surg.15 ( 5 ), 337 – 343 ( 2013 ).
  • Clark CM , FurnissM , Mackay-WigganJM . Basal cell carcinoma: an evidence-based treatment update . Am. J. Clin. Dermatol.15 ( 3 ), 197 – 216 ( 2014 ).
  • Gargiulo M , PapaA , CapassoP , MoioM , CubicciottiE , ParascandoloS . Electrochemotherapy for non-melanoma head and neck cancers: clinical outcomes in 25 patients . Ann. Surg.255 ( 6 ), 1158 – 1164 ( 2012 ).
  • Mir LM , GehlG , SersaGet al. Standard operating procedures of the electrochemotherapy: instructions for the use of bleomyicin or cisplatin administered either systemically or locally and electric pulses delivered by the Cliniporator™ by means of invasive or noninvasive electrodes . EJC Supplements ( 4 ), 14 – 25 ( 2006 ).
  • Marty M , SersaG , GarbayJRet al. Electrochemotherapy: an easy, highly effective and safe treatment of cutaneous and subcutaneous metastases: results of ESOPE (European Standard Operating Procedures of Electrochemotherapy) study . Eur. J. Cancer4 ( Suppl. ), 3 – 13 ( 2006 ).
  • IGEA clinical biophysics . www.igea.it .
  • Goldberg DP . Assessment and surgical treatment of basal cell skin cancer . Clin. Plast. Surg.24 , 673 ( 1997 ).
  • Drake DB , OishiSN . Wound healing considerations in chemotherapy and radiation therapy . Clin. Plast. Surg.22 , 31 ( 1995 ).
  • Silverman MK , KopfAW , BartRSet al. Recurrence rates of treated basal cell carcinomas. Part 3: surgical excision . J. Dermatol. Surg. Oncol.18 , 471 – 476 ( 1992 ).
  • Campana LG , ValpioneS , MocellinSet al. Electrochemotherapy for disseminated superficial metastases from malignant melanoma . Br. J. Surg.99 ( 6 ), 821 – 830 ( 2012 ).
  • Salwa SP , BourkeMG , FordePFet al. Electrochemotherapy for the treatment of ocular basal cell carcinoma; a novel adjunct in the disease management . J. Plast. Reconstr. Aesthet. Surg.67 ( 3 ), 403 – 406 ( 2014 ).
  • Mevio N , BertinoG , OcchiniAet al. Electrochemotherapy for the treatment of recurrent head and neck cancers: preliminary results . Tumori98 ( 3 ), 308 – 313 ( 2012 ).
  • Study using the MedPulser electroporation system with bleomycin to treat cutaneous and subcutaneous cancer . http://clinicaltrials.gov/show/NCT00198276 .
  • Electrochemotherapy for primary basal cell carcinoma and primary squamous cell carcinoma . www.electroporation.net .
  • Interventional procedure overview of electrochemotherapy for primary basal cell carcinoma and primary squamous cell carcinoma . www.nice.org.uk .

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.